-
公开(公告)号：EP1860119B1
公开(公告)日：2011-08-03
申请号：EP06714335.4
申请日：2006-02-22
发明人： AKAHORI, Yasushi , SUGIOKA, Atsushi, VIEQU COURT DENJIYAMA , HAYASHI, Nobuhiro , TAKASAKI, Akihiko , SUZUKI, Kazuhiro , MORITA, Miwa , KUROSAWA, Yoshikazu , IBA, Yoshitaka , SUMITOMO, Mariko , TSUTSUMI, Susumu , OGAWA, Keiko , MATSUDA, Kazuki , MURAMATSU, Chiho , TAKAHASHI, Nobuhiro, c/o The Faculty of Agriculture , FUJIYAMA, Sari , AZUMA, Masachika, c/o Inst. Antibodies Co., Ltd , UKAI, Yoshinori, c/o Inst. Antibodies Co., Ltd , MORISHITA, Kazuhiro, Miyazaki Medical College, Dept. of Biochemistry
IPC分类号： C07K16/28 , A61K39/00 , A61P35/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12Q1/02 , G01N33/15 , G01N33/50
CPC分类号： C07K16/303 , A61K2039/505 , C07K16/2803 , C07K2317/52 , C07K2317/56 , C07K2317/565 , C07K2317/622 , C07K2317/732 , C07K2319/00 , G01N33/57426 , G01N33/57438
摘要： It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressed in lung cancer cells, with an antibody, an ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treating cancer, etc.
-
公开(公告)号：EP1860119A4
公开(公告)日：2009-04-15
申请号：EP06714335
申请日：2006-02-22
发明人： AKAHORI YASUSHI , SUGIOKA ATSUSHI , HAYASHI NOBUHIRO , TAKASAKI AKIHIKO , SUZUKI KAZUHIRO , MORITA MIWA , KUROSAWA YOSHIKAZU , IBA YOSHITAKA , SUMITOMO MARIKO , TSUTSUMI SUSUMU , OGAWA KEIKO , MATSUDA KAZUKI , MURAMATSU CHIHO , TAKAHASHI NOBUHIRO , FUJIYAMA SARI , AZUMA MASACHIKA , UKAI YOSHINORI , MORISHITA KAZUHIRO
IPC分类号： C07K16/28 , A61K39/00 , A61P35/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12Q1/02 , G01N33/15 , G01N33/50
CPC分类号： C07K16/303 , A61K2039/505 , C07K16/2803 , C07K2317/52 , C07K2317/56 , C07K2317/565 , C07K2317/622 , C07K2317/732 , C07K2319/00 , G01N33/57426 , G01N33/57438
摘要： It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressed in lung cancer cells, with an antibody, an ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treating cancer, etc.
-
3.发明公开
公开(公告)号：EP1860119A1
公开(公告)日：2007-11-28
申请号：EP06714335.4
申请日：2006-02-22
发明人： AKAHORI, Yasushi , SUGIOKA, Atsushi, VIEQU COURT DENJIYAMA , HAYASHI, Nobuhiro , TAKASAKI, Akihiko , SUZUKI, Kazuhiro , MORITA, Miwa , KUROSAWA, Yoshikazu , IBA, Yoshitaka , SUMITOMO, Mariko , TSUTSUMI, Susumu , OGAWA, Keiko , MATSUDA, Kazuki , MURAMATSU, Chiho , TAKAHASHI, Nobuhiro, c/ The Faculty of Agriculture , FUJIYAMA, Sari, c/o The Faculty of Agriculture , AZUMA, Masachika, c/o Inst. Antibodies Co., Ltd , UKAI, Yoshinori, c/o Inst. Antibodies Co., Ltd , MORISHITA, Kazuhiro, Miyazaki Medical College, Dept. of Biochemistry
IPC分类号： C07K16/28 , A61K39/00 , A61P35/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12Q1/02 , G01N33/15 , G01N33/50
CPC分类号： C07K16/303 , A61K2039/505 , C07K16/2803 , C07K2317/52 , C07K2317/56 , C07K2317/565 , C07K2317/622 , C07K2317/732 , C07K2319/00 , G01N33/57426 , G01N33/57438
摘要： It is intended to clarify a molecule which is available as a target in treating or diagnosing cancer and utilize the molecule in the medical field or the research field. By treating IgSF4, which has been identified as a molecule specifically expressen in lung cancer cells, with an antibody, and ADCC activity is exerted. Based on this finding, an anti-IgSF4 antibody is provided as a means efficacious in treatig cancer, etc.
摘要翻译： 旨在澄清可用作治疗或诊断癌症并在医学领域或研究领域中利用分子的靶标的分子。 通过用抗体处理被鉴定为在肺癌细胞中特异性表达的分子的IgSF4，并施加ADCC活性。 基于该发现，提供抗IgSF4抗体作为治疗癌症等方面的有效手段。
-
-
搜索结果
3 条记录 (耗时 0.011 秒)
